Susceptibility of human T cell leukemia virus type I to nucleoside reverse transcriptase inhibitors.

Hill, Shawn A; Lloyd, Patricia A; McDonald, Shannon; Wykoff, Jennifer; Derse, David

Hill, Shawn A; Lloyd, Patricia A; McDonald, Shannon; Wykoff, Jennifer; Derse, David.

Affiliation

Hill SA; Basic Research Laboratory, Center for Cancer Research, Frederick, Maryland, USA.

J Infect Dis ; 188(3): 424-7, 2003 Aug 01.

Article in En | MEDLINE | ID: mdl-12870124

Subject(s)

Adenine/analogs & derivatives; Human T-lymphotropic virus 1/drug effects; Organophosphonates; Reverse Transcriptase Inhibitors/pharmacology; Adenine/pharmacology; Cell Line; Dideoxynucleosides/pharmacology; Human T-lymphotropic virus 1/physiology; Humans; Lamivudine/pharmacology; Microbial Sensitivity Tests; Organophosphorus Compounds/pharmacology; Stavudine/pharmacology; Tenofovir; Virus Replication/drug effects; Zalcitabine/pharmacology; Zidovudine/pharmacology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Adenine / Human T-lymphotropic virus 1 / Reverse Transcriptase Inhibitors / Organophosphonates Limits: Humans Language: En Journal: J Infect Dis Year: 2003 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links